Suppr超能文献

一位射血分数保留且无心肌99m锝标记焦磷酸盐摄取的老年心力衰竭患者皮下脂肪和骨骼肌中的野生型转甲状腺素蛋白淀粉样沉积。

Wild-Type Transthyretin Amyloid Depositions in the Subcutaneous Fat and Skeletal Muscles of a Nonagenarian Who Had Heart Failure With Preserved Ejection Fraction and No Myocardial Technetium-99m-Labeled Pyrophosphate Uptake.

作者信息

Takahashi Koji, Yoshida Satoshi, Ueda Mitsuharu, Uemura Shigeki, Inoue Katsuji

机构信息

Department of Community Emergency Medicine, Ehime University Graduate School of Medicine, Matsuyama, JPN.

Department of Dermatology, Ehime University Graduate School of Medicine, Matsuyama, JPN.

出版信息

Cureus. 2025 May 24;17(5):e84759. doi: 10.7759/cureus.84759. eCollection 2025 May.

Abstract

Misfolded amyloid fibrils composed of transthyretin (ATTR) cause ATTR amyloidosis, which is a systemic disease. ATTR amyloidosis can be divided into hereditary and wild-type forms according to the presence or absence of transthyretin ) gene mutations. Wild-type ATTR (ATTRwt) amyloidosis, a disease of the elderly, is more prevalent in men. ATTRwt is deposited in many organs and tissues, mainly the heart, lungs, ligaments, and tenosynovium. Orthopedic diseases caused by the deposition of ATTRwt in the ligaments and tenosynovium, such as carpal tunnel syndrome, biceps tendon rupture, spinal canal stenosis, and rotator cuff tears, are known to precede cardiac involvement by several years, leading to ATTRwt cardiomyopathy (ATTR-CM). ATTR-CM can coexist with common heart diseases in patients of heart failure with preserved ejection fraction (HFpEF) and aortic stenosis. Heart failure and rhythm disturbance resulting from ATTR-CM is the leading cause of mortality in patients with ATTRwt. The median life expectancy after the diagnosis of ATTR-CM is low without the administration of disease-modifying drugs. The presence or absence of cardiac involvement is defined by a left ventricular (LV) wall thickness of ≥12 mm on echocardiography, regardless of body size or sex differences. Scintigraphy with bone-avid radiotracers, including technetium-99m-labeled pyrophosphate (Tc-99m-PYP), provides sensitive imaging of myocardial ATTRwt depositions that lead to ATTR-CM. However, there are few reports of histopathologic confirmation of extracardiac ATTRwt deposition prior to myocardial deposition demonstrated by Tc-99m-PYP scintigraphy. We report the case of a 92-year-old woman with acute HFpEF and aortic valve stenosis. Tc-99m-PYP scintigraphy revealed tracer uptake in the subcutaneous fat and skeletal muscles but not in the myocardium. We suspected the patient had ATTR. Biopsy of the subcutaneous abdominal fat with tracer uptake confirmed ATTR deposition. gene sequencing revealed no variants, and the results of Tc-99m-PYP scintigraphy led to the diagnosis of ATTRwt with no obvious ATTRwt deposition in the myocardium. Extracardiac Tc-99m-PYP uptake in this case, as in orthopedic diseases due to ATTRwt depositions, reflects a condition prior to myocardial ATTRwt deposition and is considered suspicious for ATTRwt. The clinical significance of reporting this patient is to prompt future studies to test whether ATTRwt is deposited in the hearts of similar patients and whether early detection and treatment of ATTRwt will improve prognosis, which will require the accumulation of similar cases.

摘要

由转甲状腺素蛋白(ATTR)组成的错误折叠淀粉样纤维会导致ATTR淀粉样变性,这是一种全身性疾病。根据转甲状腺素蛋白(TTR)基因突变的有无,ATTR淀粉样变性可分为遗传性和野生型。野生型ATTR(ATTRwt)淀粉样变性是一种老年疾病,在男性中更为普遍。ATTRwt沉积于许多器官和组织,主要是心脏、肺、韧带和腱鞘。已知ATTRwt在韧带和腱鞘中沉积引起的骨科疾病,如腕管综合征、肱二头肌肌腱断裂、椎管狭窄和肩袖撕裂,比心脏受累早数年出现,进而导致ATTRwt心肌病(ATTR-CM)。ATTR-CM可与射血分数保留的心力衰竭(HFpEF)和主动脉瓣狭窄患者的常见心脏病共存。ATTR-CM导致的心力衰竭和心律失常是ATTRwt患者死亡的主要原因。在不使用疾病修饰药物的情况下,ATTR-CM诊断后的中位预期寿命较低。无论体型或性别差异如何,超声心动图显示左心室(LV)壁厚度≥12mm可定义有无心脏受累。使用包括锝-99m标记焦磷酸盐(Tc-99m-PYP)在内的亲骨放射性示踪剂进行闪烁扫描,可对导致ATTR-CM的心肌ATTRwt沉积进行敏感成像。然而,在Tc-99m-PYP闪烁扫描显示心肌沉积之前,关于心外ATTRwt沉积的组织病理学证实的报道很少。我们报告了一例92岁患有急性HFpEF和主动脉瓣狭窄的女性病例。Tc-99m-PYP闪烁扫描显示皮下脂肪和骨骼肌有示踪剂摄取,但心肌无摄取。我们怀疑该患者患有ATTR。对有示踪剂摄取的腹部皮下脂肪进行活检证实有ATTR沉积。基因测序未发现变异,Tc-99m-PYP闪烁扫描结果诊断为心肌无明显ATTRwt沉积的ATTRwt。本例的心外Tc-99m-PYP摄取,与ATTRwt沉积引起的骨科疾病一样,反映了心肌ATTRwt沉积之前的情况,被认为是ATTRwt可疑表现。报告该患者的临床意义在于促使未来的研究去测试ATTRwt是否沉积于类似患者的心脏,以及ATTRwt的早期检测和治疗是否会改善预后,这将需要积累类似病例。

相似文献

2
"Loss of Bone Signal" on 99m Tc-Labeled Pyrophosphate Scintigraphy in a Patient With Wild-Type Transthyretin Amyloidosis.
Clin Nucl Med. 2024 Aug 1;49(8):767-770. doi: 10.1097/RLU.0000000000005236. Epub 2024 Apr 18.
3
Suspicion, screening, and diagnosis of wild-type transthyretin amyloid cardiomyopathy: a systematic literature review.
ESC Heart Fail. 2022 Jun;9(3):1524-1541. doi: 10.1002/ehf2.13884. Epub 2022 Mar 27.
5
The use of diflunisal for transthyretin cardiac amyloidosis: a review.
Heart Fail Rev. 2022 Mar;27(2):517-524. doi: 10.1007/s10741-021-10143-4. Epub 2021 Jul 16.
6
Wild-Type Transthyretin Amyloidosis With 99mTc-PYP Uptake in the Extracardiac Soft Tissues But Not in the Myocardium.
Clin Nucl Med. 2024 Dec 1;49(12):1136-1138. doi: 10.1097/RLU.0000000000005521.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Endovascular treatment for ruptured abdominal aortic aneurysm.
Cochrane Database Syst Rev. 2017 May 26;5(5):CD005261. doi: 10.1002/14651858.CD005261.pub4.

本文引用的文献

1
Epidemiology of transthyretin (ATTR) amyloidosis: a systematic literature review.
Orphanet J Rare Dis. 2025 Jan 16;20(1):29. doi: 10.1186/s13023-025-03547-0.
2
Transthyretin amyloid cardiomyopathy: a paradigm for advancing precision medicine.
Eur Heart J. 2025 Mar 13;46(11):999-1013. doi: 10.1093/eurheartj/ehae811.
3
Wild-Type Transthyretin Amyloidosis With 99mTc-PYP Uptake in the Extracardiac Soft Tissues But Not in the Myocardium.
Clin Nucl Med. 2024 Dec 1;49(12):1136-1138. doi: 10.1097/RLU.0000000000005521.
6
Cardiac Amyloidosis Due to Transthyretin Protein: A Review.
JAMA. 2024 Mar 5;331(9):778-791. doi: 10.1001/jama.2024.0442.
8
Risk stratification in transthyretin-related cardiac amyloidosis.
Front Cardiovasc Med. 2023 Mar 21;10:1151803. doi: 10.3389/fcvm.2023.1151803. eCollection 2023.
9
Sex differences among patients with transthyretin amyloid cardiomyopathy - from diagnosis to prognosis.
Eur J Heart Fail. 2022 Dec;24(12):2355-2363. doi: 10.1002/ejhf.2646. Epub 2022 Aug 16.
10
99mTc-Pyrophosphate Scintigraphy Can Image Tracer Uptake in Skeletal Trunk Muscles of Transthyretin Cardiac Amyloidosis.
Clin Nucl Med. 2023 Jan 1;48(1):18-24. doi: 10.1097/RLU.0000000000004397. Epub 2022 Sep 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验